Adverse events temporally associated with meningococcal vaccines.
OBJECTIVE
To determine the incidence of severe adverse events temporally associated with meningococcal vaccines administered as part of a mass vaccination program.


METHODS
Retrospective descriptive study of events reported to a passive provincial surveillance system.


METHODS
The province of Quebec.


METHODS
The 1,198,751 individuals aged 6 months to 20 years who were vaccinated against meningococcal disease between Dec. 27, 1992, and Mar. 31, 1993.


METHODS
Total numbers and rates of severe adverse events, including allergic reactions, anaphylactic reactions, neurological events (other than abnormal crying and screaming) and other serious or unusual events.


RESULTS
A total of 118 reports of severe adverse events were selected from the surveillance system. The most frequent were allergic reactions (9.2 per 100,000 doses). Few anaphylactic or neurologic reactions were reported (0.1 and 0.5 per 100,000 doses respectively). There were no reports of sequelae or of encephalopathy, meningitis or encephalitis.


CONCLUSIONS
Meningococcal vaccines seem to be associated with fewer adverse events than have previously been reported. Existing surveillance programs are useful for determining the incidence of adverse events temporally associated with vaccines.
Yergeau
A
A
Field Epidemiology Division, Laboratory Centre for Disease Control, Ottawa, Ont.
Alain
L
L
Pless
R
R
Robert
Y
Y
D000293:Adolescent; D000328:Adult; D000707:Anaphylaxis / Q000209:etiology; D001428:Bacterial Vaccines / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000209:etiology; D017589:Immunization Programs; D007223:Infant; D008297:Male; D022401:Meningococcal Vaccines; D009422:Nervous System Diseases / Q000209:etiology; D011792:Quebec; D012189:Retrospective Studies
D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines